Resurrection of sildenafil: potential for Huntington’s Disease, too?

The phosphodiesterase-5 inhibitor sildenafil was postulated to reduce the risk for Alzheimer’s Disease. Since preclinical data revealed beneficial effects in Huntington’s Disease (HD), we now for the first time investigated effects of sildenafil in HD patients using the database ENROLL-HD. We demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Achenbach, Jannis, Faissner, Simon, Saft, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Short Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363275/
https://www.ncbi.nlm.nih.gov/pubmed/35633374
http://dx.doi.org/10.1007/s00415-022-11196-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363275/
https://www.ncbi.nlm.nih.gov/pubmed/35633374
http://dx.doi.org/10.1007/s00415-022-11196-7

Ejemplares similares